Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.52 |
| ▸ | PPARA | Q07869 | 3/20 | 0.52 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | DHODH | Q02127 | 1/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 1/20 | 0.41 |
| ▸ | TYMS | P04818 | 1/20 | 0.41 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6222370 | 0.87 | ALPL (0.43) | PPARGPPARAPPARDTARBP2ALOX5 | |
| SCHEMBL7571353 | 0.85 | CYP1A2 (0.46) | PPARGPPARATARBP2ALOX5DHODH | |
| SCHEMBL7578265 | 0.83 | ALOX5 (0.48) | PPARGPPARAPPARDTARBP2ALOX5 | |
| SCHEMBL21790496 | 0.80 | PPARG (0.46) | PPARGPPARAMRGPRX4PPARDALDH1A1 | |
| SCHEMBL21790495 | 0.80 | PPARG (0.46) | PPARGPPARAMRGPRX4PPARDALDH1A1 | |
| SCHEMBL1598817 | 0.79 | SMN1; SMN2 (0.51) | MRGPRX4TYMSALDH1A1MAPTHPGD | |
| SCHEMBL6976915 | 0.79 | NPC1 (0.51) | TARBP2ALOX5ALDH1A1MAPTHPGD | |
| SCHEMBL1598707 | 0.79 | TDP1 (0.51) | PPARGRXRARXRBTYMSALDH1A1 | |
| SCHEMBL10501271 | 0.78 | ALDH1A1 (0.46) | TARBP2ALOX5ALDH1A1MAPTHPGD | |
| SCHEMBL1911874 | 0.77 | MRGPRX4 (0.54) | PPARGPPARAMRGPRX4PPARDRXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020086892-A1 | For controlling animal pests, in particular: insects, arachnids and nematodes | BAYER AKTIENGESELLSCHAFT (DE) | 2002-07-04 | — | — | US | disclosed |
| US-6410581-B1 | INSECTICIDES, MITICIDES, NEMATOCIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086892-A1 | For controlling animal pests, in particular: insects, arachnids and nematodes | ATXN2, HAX1, ANTXR2 | PPARG 4297/4885PPARA 4505/4885MRGPRX4 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.